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1. Is there significant deficiency in Yes, there is. As a whole, the means of Serum achieved 
plasma Magnesium level among Magnesium in ACS is significantly lower 
Acute Coronary Syndrome patients compared to the control. However upon further 
? analysis, it was found that the subgroup 
NSTEMI contributed largely to the low level of 
the Magnesium. In individual analysis, it was 
found that there was no difference in terms of 
the means of Serum Magnesium in STEMI and 
UA patients. 
2. Is Magnesium level investigation Yes, it is worthwhile. The study showed that achieved 
worthwhile taken, ie show significant there is a significant proportion of 
results and subsequently change hypomagnesemia in ACS patients and all of its 
management? subgroups. This is especially true in NSTEMI 
whereby almost 30% of the population present 
with hypomagnesemia. The presence of 
hypomagnesemia indicates the suggested need 
of Magnesium supplements in this group. 
Although previous large studies like the ISIS-4 
and MAGIC showed routine infusion of 
Magnesium in MI patients were not warranted, 
they did not address the need of giving 
Magnesium in hypomagnesemic portions of the 
population. 
3. Is there any significant difference There is a significant difference between the achieved 
in terms of Magnesium level in subgroups of ACS. The means ofNSTEMI 
comparison between subsets of showed significantly lower Magnesium level 
Acute Coronary Syndrome compared to STEMI and UA. No significant 
(Unstable Angina, Non ST Elevation difference however was found between the 
Myocardial Infarct and ST elevation means ofSTEMI and UA. On further analysis, it 
Myocardial Infarct)? was also found that there was significant 
proportion of hypomagnesemia in all subgroups 
compared to the control group. In the case of 
STEMI, there was also a significant proportion 
ofhypermagnesemia compared to the control 
healthy population. From the study, Odds Ratios 
were calculated for each group and it was found 
that the Odds Ratio of getting STEMI, UA and 
NSTEMI in patients presenting with classical 
clinical signs and symptoms and 
hypomagnesemic are higher compared to the 
control population. This may be helpful in the 
case ofNSTEMI, whereby there is difficulty of 
differentiating between NSTEMI and UA. If 
hypomagnesemia is present, the Odds of getting 
NSTEMI compared to UA is higher. However, 
this may be only used as an adjunct and not as a 
diagnostic tool. 
4. Is there a role of Magnesium therapy Not as a routine. The majority of patients still achieved 
in Acute Coronary Syndrome patients present with normomagnesemia. However, 
among local population? Magnesium supplements should still be 
considered in patients with established 
hypomagnesemia demonstrated by the lab 
result. The proportion of ACS population 
presenting with hypomagnesemia is till 
significant compared to the control healthy 
group. 
5. Can knowledge of Serum Magnesium Odds Ratio of getting STEMI, UA and NSTEMI achieved 
level contribute to diagnosis-making in patients presenting with classical clinical 
process of Acute Coronary Syndrome signs and symptoms and hypomagnesemic are 
patients? higher compared to the control population. This 
may be helpful in the case ofNSTEMI, whereby 
there is difficulty of differentiating between 
NSTEMI and UA. If hypomagnesemia is 
present, the Odds of getting NSTEMI compared 
to UA is higher. However, this may be only 
used as an adjunct and not as a diagnostic tool. 
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ABSTRAK 
Kajian Serum Magnesium Dalam Pesakit-pesakit Sindrom Koronari Akut 
Alzamani MI, Zurkurnai Y, Rashidi A, Hasenan N 
Hospital U niversiti Sains Malaysia 
2005 
PENGENALAN Terdapat banyak kajian samada in-vitro atau klinikal yang 
menunjukkan kemungkinan peranan yang dimainkan oleh magnesium dalam sindrom 
koronari akut. Banyak kajian menunjukkan paras magnesium yang rendah 
(hipomagnesemia) dalam sindrom koronari akut. Bagaimanapun tidak ada kajian 
seumpamanya dijalankan di Malaysia. Terdapat keperluan untuk mengetahui samada 
terdapat hypomagnesemia dalam sindrom ini di kalangan populasi pesakit di Negara ini. 
Pengetahuan tentang status magnesium ini akan menjadi panduan bagi kajian lanjut, 
rawatan atau rawatan sampingan menggunakan magnesium pada pesakit sindrom ini pada 
masa hadapan. 
OBJEKTIF 
1. Untuk menentukan sama ada terdapat paras kekurangan magnesium di dalam 
pesakit sindrom koronari akut 
2. Untuk justifikasi siasatan magnesium sebagari rutin bersama siasatan 
elektrolit lain seperti Na danK 
3. To determine any differences of serum Magnesium between ACS subgroups: 
4. Menentukan perbezaan serum magnesium di antara subpopulasi sindrom 
koronari akut : STEMI, UA dan NSTEMI 
5. Sebagai asas untuk kajian lanjut berkenaan rawatan menggunakan magnesium 
di kalangan pesakit sindrom coronary akut. 
METODOLOGI Paras magnesium dalam serum 420 pesakit yang datang dengan 
gej ala sakit dada di ambil di Jabatan Kecemasan. Setelah disahkan berdasarkan kriteria 
WHO dan Panduan Praktis Klinikal Kementerian Kesihatan Malaysia (berdasarkan EKG, 
enzim kardiak atau angiogram), sebanyak 255 dipastikan sebagai kes sindrom coronary 
akut (64 STEMI, 155 UA dan 37 NSTEMI. Baki 165 disahkan bukan dalam kategori 
sindrom koronari akut. Sebanyak 95 kes control diambil sebagai bandingan (terdiri 
daripada sukarelawan denganjulat umur dari ~ belasan hingga 60an )Hanya satu 
mesin digunakan untuk mengukur serum magnestum .. 
KEPUTUSAN Terdapat perbezaan yang signifikan di antara purata serum 
magnesium sindrom koronari akut dan kontrol (p=0.038; <0.05) There is no significant 
difference between the means ofNon-ACS and the Control group; p= 0.115 (> 0.05) 
. Ujian ANOV A satu hala menunjukkan perbezaan signiftkan di dalam subpopulasi 
sindrom koronari akut secara amnya (P < 0.05) Terdapat perbezaan signiftkan di antara 
STEMI dan NSTEMI (p=0.007) serta di antara STEMI dan kontrol (p=O.OOS).Tiada 
erbezaan signifikan di antara purata serum magnesium STEMI dan kontrol ;p= 0.867 (> 
~.OS). Tiada perbezaan signifikan di antara purata serum magnesium UA dan kontrol p= 
0.089 (> 0.05). Terdapat perbezaan signifikan di antara purata NSTEMI dan kontrol; p= 
0.002 (< 0.05). Hypomagnesemia terdapat di dalam: 12.5% ofSTEMI(p<0.05), 9.7% of 
UA(p>0.05), 29.7 % ofNSTEMI(p<0.05), 10.3% dalam kumpulan bukan sindrom 
koronari akut (pesakit kardiak) p<0.05), 6.9% pesakit bukan sindrom koronari akut 
(bukan pesakit kardiak) (p>0.05) dan 3.2% dalam pesakit kontrol. 9.4% of STEM! 
memiliki paras hipermagnesemia. 'Odd's Ratio' bagi mendapat sindrom koronari akut 
dengan kehadiran hipomagnesemia adalah 4.559 kali berbanding kontrol (95% Julat 
Keyakian di antara 1.364 and 15.236).P<0.05. 'Odd's Ratio' untuk mendapat STEMI 
dengan kehadiran hipomagnesemia dalam pesakit yang simtomatik adalah 4.381 kali 
berbanding kontrol. (Julat keyakinan 95% di antaral.l16 and 17.204) ;P<0.05. 'Odd's 
Ratio' untuk mendapat NSTEMI dengan kehadiran hipomagnesemia dalam pesakit yang 
simtomatik adalah 11.795 kali berbanding kontrol (Julat Keyakinan 95% di antara 3.022 
dan 46.032). P = 0.000 ( <0.05) 
RUMUSAN 
Berbanding kontrol, terdapat paratusan hipomagnesemia yang signifikan di dalam 
kumpulan sindrom koronari akut dan setiap subpopulasi. NSTEMI memiliki paras 
hipomagnesemia yang tertinggi. Fakta bahawa kebanyakan pesakit STEMI dalam status 
normomagnesemia dan 9.4% dalam hipermagnesemia mungkin menjelaskan mengapa 
kajian besar seperti ISIS-4 dan MAGICA tidak menunjukkan sebarang perbezaan bagi 
pemberian magnesium kepada pesakit-pesakit miokardial infark. Pemberian serum 
magnesium boleh diberikan hanya kepada pesakit yang datang dengan hipomagnesemia. 
Hipomagnesemia di dalam pesakit dalam pesakit sindrom koronari akut boleh digunakan 
sebagai bantuan bagi membuat diagnosa. Peranan magnesium dalam sindrom koronari 
akut tidak harus diabaikan. Kajian lanjut diperlukan bagi pemberian magnesium untuk 
pesakit yang benar-benar datang dengan hipomagnesemia. 
ABSTRACT 
The Study Of Serum Magnesium Level in Acute Coronary Syndrome 
Patients 
Alzamani MI, Zurkurnai Y, Rashidi A, Hasen an N 
Hospital Universiti Sains Malaysia 
2005 
INTRODUCTION There had been many studies done in the past either in-vitro or 
clinically indicating the possible role that Magnesium may play in acute coronary 
syndrome. Many studies showed the presence of hypomagnesemia in coronary artery 
disease and also during the attack of myocardial infarct. However there is hardly any 
studies done on Magnesium done in Malaysia, none with regards to coronary artery 
disease or acute coronary syndrome. There is a need to know whether there is 
hypomagnesemia in Acute Coronary Syndrome in the local population. Knowledge on 
this will serve as a guide on future investigations, studies and treatment of Acute 
Coronary Syndrome or as an adjunct of ACS treatment. 
OBJECTIVES 
1. To ascertain whether there is a significant level ofMg deficiency among the 
Acute Coronary Syndrome patients in USM hospital 
2. To justify Mg investigations as a routine investigation together with other 
electrolytes investigation like Na and K 
3. To determine any differences of serum Magnesium between ACS subgroups: 
STEMI,UA and NSTEMI 
4. To fonn a basis for further investigations regarding Magnesium treatment in 
ACS patients 
METHODOLOGY The Serum Magnesium level of 420 patients with chest pain 
were taken at the Emergency Department. Upon confinnation based on WHO criteria and 
Malaysian Ministry of Health's Clinical Practice Guidelines(based on clinical, ECG, 
cardiac enzymes or angiogram). 255 were confrrmed as genuine cases of Acute Coronary 
Syndrome(64 ST-Elevated Myocardial Infarct, I 55 Unstable Angina 37 were confirmed 
as Non-ST Elevated Myocardial Infarct). The remaining 165 were non-Acute Coronary 
Syndrome cases. A total of 95 control cases made up of healthy volunteers (age range 
from late teen to elderly) were taken for comparison Only one machine was used, 
utilizing the same Magnesium ion measurement method for all samples. 
RESULTS There is a significant difference between the means of ACS and the 
Control group; p= 0.038 ( < 0.05) . There is no significant difference between the means of 
Non-ACS and the Control group; p= 0.115 (> 0.05) .One way ANOVA test showed 
significant difference in the group as a general (P< 0.05).There are significant differences 
between : STEMI and NSTEMI (p=0.007) and STEMI and CONTROL (p=0.005). There 
is no significant difference between the means of STEMI and the Control group p= 0.867 
(> 0.05) There is no significant difference between the means ofUA and the Control 
group p= 0.089 (> 0.05). There is significant difference between the means ofNSTEMI 
and the Control group p= 0.002 (< 0.05). Hypomagnesemia was present in: 12.5% of 
STEMI(p<0.05), 9.7% ofUA(p>0.05), 29.7% ofNSTEMI(p<0.05), 10.3% ofNon-ACS 
(Cardiac Origin)(p<0.05), 6.9% ofNon-ACS (Non-cardiac Origin)(p>0.05) and 3.2% of 
control patients. 9.4% ofSTEMI patients had hypermagnesemia. The Odd's Ratio for 
getting Acute Coronary Syndrome in the presence of hypomagnesemia in symptomatic 
patients is 4.559 times compared to normal control. (95% Confidence Interval between 
1.364 and 15.236).P<0.05. The Odd's Ratio for getting STEMI in the presence of 
hypomagnesemia in symptomatic patients is 4.381 times compared to normal control. 
(95% Confidence Interval between 1.116 and 17.204) ;P<0.05.The Odd's Ratio for 
getting NSTEMI in the presence of hypomagnesemia in symptomatic patients is 11.795 
times compared to normal control. (95% Confidence Interval between 3.022 and 46.032). 
p = 0.000 (<0.05) 
CONCLUSIONS 
There is a significant difference of serum magnesium level in ACS group 
compared to control. Mean serum magnesium tend to be lower in ACS group. Compared 
to the control healthy population, there is a significant proportion of hypomagnesemia in 
ACS group as a whole as well as each subgroup. NSTEMI has the highest proportion of 
hypomagnesemia. The fact that the majority of the STEMI patients were in 
normomagnesemic state as well as 9.4% of them in hypermagnesemic state may explain 
why routine infusion of Magnesium in large studies like the ISIS-4 and MAGICA did not 
show any significant difference .. Routine investigation for Serum Magnesium may be 
done since there is a significant proportion of ACS patients in hypomagnesemic state 
compared to conrol healthy population. Hypomagnesemia in patients presenting with 
chest pain may be used as an adjunct for diagnosis making. The role of Magnesium 
infusion for ACS syndrome patients should not be dismissed. Further study with regard to 
its role especially in patients with hypomagnesemia during ACS attack needs to be done. 
SALINAN MANUSKRIP 
MANUSCRIPT DRAFT 
The Study Of Serum Magnesium Level in Acute Coronary Syndrome Patients 
Alzamani Ml*, Rashidi A**, Hasenan N**, Zurkurnai Y** 
*Emergency Department, Hospital Kuala Lumpur 
**Hospital Universiti Sains Malaysia 
Introduction 
Some studies in the past showed presence of hypomagnesemia in Myocardial 
Infarct patients 1•2 • Magnesium seems to be able to dilate the coronary arteries 
particularly in situations in which coronary vascular reactivity appears pathological. In 
fact magnesium improves vasospastic angina and dilates segments of human coronary 
arteries 3•4 • Moreover, magnesium suppresses angina induced by exercise by improving 
the regional myocardial flow 5 • In addition, some studies provide supportive evidence 
that supplementation of magnesium chloride may reduce the incidence of fatal and 
nonfatal arrhythmias after an infarct 6 • In fact, quality of life of Acute Coronary 
Syndrome(ACS) patients given magnesium infusion improved significantly 7 • 
In view of no studies regarding the level of Serum Magnesium during the attack 
of ACS in patients in Asia before, there is a need to at least know the level of serum 
Magnesium in Acute Coronary Syndrome which is made up of ST -elevated Myocardial 
Infarct (STEMI),Unstable Angina (UA) and Non-ST Elevated Myocardial Infarct 
(NSTEMI) in the population. Knowledge on this will serve as a guide on future 
investigations, studies and treatment of the disease. 
Aims of The Study 
~To determine the serum Magnesium in ACS as compared to healthy,normal control 
population 
~To ascertain whether there is a significant level ofMg deficiency among the Acute 
Coronary Syndrome patients (in terms of both means and proportion of hypomagnesemia, 
compared to normal p~pul~tion) . . . . . 
~To justify Mg investigations as a rout1ne 1nvest1gat1on together With other electrolyte 
investigations like Na and K 
~To determine any differences between subgroups of ACS 
~To determine whether knowledge ofMagnesium level among ACS patients can 
contribute to diagnosis-making process 
Methodology 
The serum Magnesium level of 420 patients with chest pain were taken at the 
Emergency Department. Upon confirmation based on WHO criteria, 255 were confirmed 
as genuine cases of Acute Coronary Syndrome(64 STEMI,155 UA and 37 were 
confirmed as NSTEMI). 95 healthy co?trol samples (age range from late teen to elderly) 
were taken from volunteers for companson. The study was approved by the ethical 
committee and carried out with University short term grant. The Serum Magnesium was 
measured using the Calmagite method. The same machine (Hitachi 912 Automatic 
Analyzer) was used for all samples taken. Rigorous Quality Control was applied for the 
reagent testing and machine configuration in the lab 
Results 
The means of Serum Magnesium in Populations of Acute Coronary Syndrome patients 
are as tabulated in Table 1 · 
Table 1 
ACS 256 
0.88±0.15 0.91±0.10 0.038 
NSTEMI 
0.81±0.16 0.91 ±0.10 
0.09 155 
0.91±0.10 0.87 
STEMI 64 
0.91±0.16 
0.91±0.10 
UA 
0.88±0.14 
37 0.001 
*Note: Population (N) of Healthy Control Population is 95. 
H an
d hypermagnesemia state is determined by mean ± 2 SD derived from the 
ypo,normo 1 . healthy control population of the loc~l popu atwn : 
H semia. Serum Magnesmm ~ 0.70 mmoUL 
ypomagne ei·a: Serum Magnesium~ 0.71 and ~1.12 mmoVL 
Normomagnes · . 
emia . Serum Magnesmm ~1.13 Hypermagnes . · 
"fi t difference when compared to normal population noted in ACS and 
** SigOI 1can 
NSTEMI groups (p<O.OS) 
Graph 1 : Proportion of Magnesium Level 
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Ill Nonnomagnesemia 
0 Hypennagnesemia 
Logistic Regression : Odds Ratio For Getting ACS 
The Odd's Ratio for getting Acute Coronary Syndrome in the presence of 
hypomagnesemia in symptomatic patients is 4.559 times compared to normal control. 
(95% Confidence Interval between 1.36 and 15.24). P= 0.014 
Logistic Regression : Odds Ratio for getting STEMI 
(STEMI VS CONTROL) 
The Odd' s Ratio for getting STEMI in the presence of hypomagnesemia in symptomatic 
patients is 4.381 times compared to normal control. (95% Confidence Interval between 
1.12 and 17 .20). The lower border is > 1.0 with P=0.034 ( <0.05) and therefore 
significant. 
Logistic Regression: Odds Ratio for getting UA 
(UA VS CONTROL} 
The Odd's Ratio for getting UA in the presence of hypomagnesemia in symptomatic 
patients is 3.286 times compared to normal control. (95% Confidence Interval between 
0.93 and 15.24). Nevertheless this OR is not significant since the lower interval is less 
than 1.0. P=0.66(>0.05) 
Logistic Regression :Odds Ratio for getting NSTEMI 
(NSTEMI vs CONTROL) 
The Odd's Ratio for getting NSTEMI in the presence of hypomagnesemia in 
symptomatic patients is 11.795 times compared to normal control. (95% Confidence 
Interval between 3.02 and 46.03). P = 0.000 (<0.05). 
Discussions 
Magnesium infusion was even considered in some patients with Myocardial 
Infarct who were not elligible for thrombolytics with favourable results. A global 
analysis by Homer of magnesium therapy in acute myocardial infarction found that this 
treatment was safe and useful 8 • However two double-blind controlled mega-trials had 
cast doubt on this point of view 9' 10 • The MAGIC trial, despite not showing any 
difference of mortality did show improvement of quality of life in those who did receive 
the treatment 7• Cassells stated that patients with subnormal magnesium concentrations 
should be given magnesium in AMI 11 • 
Two studies concerning the use of magnesium and mortality after AMI predated 
the introduction of thrombolysis. Homer reported that i.v. administration of magnesium 
was associated with a 49% reduction in the incidence of ventricular tachycardia (VT) and 
ventricular fibrillation (VF) and that there was a smaller non-significant reduction in the 
incidence of asystole and electromechanical dissociation (EMD) in the treatment groups. 
Overall, there was a 54% reduction in mortality associated with administration of 
magnesium 8 • Teo and colleagues also demonstrated that administration of magnesium 
was a safe and effective method of reducing arrhythmias and mortality in AMI 12 • Homer 
suggested that the anti-arrhythmic effect of magnesium was the main mechanism by 
which it reduced mortality· 
In this study, there was a significant deficiency of the means of plasma 
Magnesium level among Acute Coronary Syndrome patients (Table 1 ). As a whole, the 
means of Serum Magnesium in ACS is significantly lower compared to the control. 
However upon further analysis, it was found that the subgroup NSTEMI contributed 
largely to the low level of the Magnesium. In individual ~alys~s, it was found that there 
was no difference in terms of the means of Serum Magnestum tn STEMI and UA 
patients. By itself, the Magnesium level of ACS lies in the normal range but tends to be 
on the lower range. 
.. 
The mean of Serum Magnesium in ACS group (0.88±0.15) was still within the 
normal range but there was a significant difference when compared to the control group; 
p= 0.038 (Table 1). The lower mean of serum Magnesium was found in NSTEMI 
patients. Hypomagnesemia was present in: 12.5% ofSTEMI(p=O.OO), 9.7% of 
UA(p=0.039), 29.7% ofNSTEMI(p=O.OO) and 3.2% of control patients. 9.4% ofSTEMI 
patients actually had hypermagnesemia (Graph 1). 
There was significant difference in terms of Magnesium level in comparison 
between subsets of Acute Coronary Syndrome (Unstable Angina, Non ST Elevation 
Myocardial Infarct and ST elevation Myocardial Infarct) • The means ofNSTEMI 
showed significantly lower Magnesium level compared to STEMI and UA. No 
significant difference however was found between the means of STEMI and UA. In 
further analysis, it was also found that there was significant proportion of 
hypomagnesemia in all subgroups compared to the control group. In the case of STEMI, 
there was also a significant proportion of hypermagnesemia compared to the control 
healthy population. 
Postulation That Explains the Result of This Study 
Based on the findings of this study, postulation as regards why such results were 
obtained is made based on these principles: 
1. Ischemic areas causes Magnesium to go out of intracellular area into the circulation 
2. Ischemia produces stress to the body which triggers production of catecholamines from 
the adrenal gland 
3. Catecholamines will be brought by blood circulation to ischemic area and there, causes 
adipolysis which produces free fatty acid (FF A) in the circulation 
4. FFA binds to Magnesium and produces less available free Magnesium detectable by 
lab investigation. 
5. Results of nonno, hypo and h?'Pe~agnese_mia in ACS patients depends on the .type of 
ACS and the duration and seventy of Ischemia. The net result depends on the vanable of 
Magnesium going out of cell into circulation during ischemia, the amount of 
catecholamines 
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available is less 
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During ischemia, Mg goes out_from ~yoca~di~m into the circulation. Compared 
to Unstable angina or NSTEMI, seventy of 1:chem1a IS more as the occlusion of vessel is 
complete. This produces significant areas of mfarct. The amount ofMg going out of 
myocardium is therefore expected to be mu_ch more than both UA and NSTEMI. 
Nevertheless, at the same time, catechol~mes (produced as ~ result of stress caused by 
ischemia) carmot pass through the oc~luswn. T~er~fore there IS not much adipolysis at 
the area beyond the occluded area.Thrs results m little amount of free fatty acid (FFA) 
produced into circulation. Therefore, less FF A is available and therefore, less Mg would 
bind with the FF A.As a result, Mg coming out of myocardium are relatively free as the 
amount of FFA available is less. On top of that, more Mg goes back into the myocardium 
to save the depleted A TP as rescue mechanism. As the end result, the net result of Serum 
Magnesium in circulation is either same with normal population or slightly higher (as 
shown in this study) 
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. · hem1·a Magnesium goes out from myocardium into the circulation. Dunng ISC , 
. f. h ·a in NSTEMI is expected to be more compared to unstable angina as Seventy o ISC emt h . . . 
. f sel is complete (thoug m mterm1ttent manner or at area of 
the occlusiOn o ves · · .~ A 1 · 
. . . ) d cino areas of microimarct. t t 1e same tlme, catecholamines 
microcJrculat.wnh pr? utres~ to patients can pass through the intermittent occlusion 
d ced by 1sc emtc s . ' pro u . 1 . and increase the FFA.Mg commg out of myocardium binds to precipitating ad1po ysJs 
FF A. At the same time too, more Magnesium goes back into the myocardium to save the 
depleted A TP as rescue mechanism. As an end-result, less Magnesium is in circulation. 
Therefore, the serum level of Mg in NSTEMI appear significantly lower than normal 
population 
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. . h ·a Mg goes out from myocardium into the circulation. Nevertheless, 
ow:mg ~~ ~~ia is less compared to infarct as the occlusion of vessel is not 
the seventy~ .1sc tM aoes out of myocardium. Catecholamines can pass through the compl~te. Mmt~l~ f ggoadipolysis and increase the FFA. Magnesium coming out of 
occlusiO~ ' pre~~~~t~~~FA. Some Mg goes back into t~e myocardium to save the depleted 
myocardtum b h ·sm As the end result: Magnesium goes out of the cell more. 
A TP as rescue mec aru · 
Nevertheless, plenty of available FF A binds the free Magnesium resulting in the net 
normal range of Magnesium level. 
Serum Magnesium can be used as an adjunct to diagnosis-making process of 
Acute Coronary Syndrome patients - especially if all other causes of hypomagnesemia is 
ruled out eg diarrhea etc. From the study, Odds Ratios were calculated for each group and 
it was found that the Odds Ratio of getting STEMI, UA and NSTEMI in patients 
presenting with classical clinical signs and symptoms and hypomagnesemic are higher 
compared to the control population. This is especially helpful in the case ofNSTEMI, 
whereby there is difficulty of differentiating between NSTEMI and UA. If 
hypomagnesemia is present, the Odds of getting NSTEMi compared to UA is higher. 
However, this is only used as an adjunct and not the sole diagnostic tool. 
Magnesium therapy in Acute Coronary Syndrome patients among local 
population should be considered especially in NSTEMI patients . The fact that significant 
proportion of hypomagnesemia is noted in NSTEMI patients should reignite interest of 
magnesium therapy in this group of patients. Morever with the evidence that quality of 
life is improved among patients given magnesium as treatment in trial like that of 
MAGIC 2000. (MAGIC 2000). Further study regarding giving magnesium infusion in 
NSTEMI patients is needed. 
Conclusions 
The Serum Magnesium of ACS, particularly NSTEMI was within the normal 
range but tend to be at the lower range. Comp~e~ to the control healthy population, there 
as a significant proportion of hypomagnesemia In ACS group as a whole as well as 
w h subgroup. NSTEMI group had the highest proportion of hypomagnesemia- a fact 
eac · th · thi d d d 
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"Study of Serum Magnesium in Acute Coronary Syndrome Patients" 
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1.0 Introduction 
This study was approved by the ethical committee and carried out since April 2004. This 
study was done utilizing short-term grant under Associate Professor Dr Zurkurnai Yusuf. 
The data collection was completed about 1 year later (April 2005). The write-up was 
completed in November 2005.1t was reviewed extensively by internal and external 
examiner and was accepted by the as a partial fulfilment of the Master in Medicine 
(Emergency). This study also is the first in the world that included population ofNon-ST 
Elevated Myocardial Infarction Acute Coronary Syndrome patients. 
The abstract of the study is attached in this letter. 2 copies of the full thesis are in the 
keeping of the Graduate's Office. 
2.0 Achievements 
The paper was presented twice at national level and at both times, it was chosen as best 
paper. The author was ~ctually off~red to do a pHD by one of the examiners following 
him being impressed wtth the qualtty of the paper 
Presentations Location Achievement 
1. 11m National Conference of Universiti Sains Best Paper (1st place) in 
Health and Medical Sciences. Malaysia Kubang Kerian Medical Category 
(Oral Presentation) 
2. 40m Malaysia-Singapore Sunway Pyramid, Accepted for 
Congress of Medicine (organized Petaling Jaya, Selangor presentation 
by the Academy of Medicine, 
Malaysia) 
3. 1om National Conference and I 01 Mall, Putrajaya Best Paper ( 1 Sl place) in 
Scientific Meeting of Emergency Medical Category 
Medicine 
(Oral Presentation) 
3.0 International Level 
Th paper was accepted and presented at the 40th Singapore-Malaysia Congress of 
Me~icine held at sunway Hotel, Malaysia. 
4.0 Future Plans Regarding the Study 
Plans are underway for presentation at International level (4th Mediterranean Conference 
on Emergency and Disaster Medicine) in Sorrento, Italy in September 2007. The paper is 
already accepted for presentation in the conference. 
Works are underway to have it published in journal. 
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THE STUDY OF SERUM MAGNESIUM LEVEL IN A CUTE CORONARY 
S YNDROME PATIENTS 
Alzamani MI*, Rashidi A*, Hasenan N**, Zurkurnai Y*'''* 
* Department of Emergency Medicine, '''* Department of Chemical Pathology, 
**''' Cardiac Unit, Department of Medicine, School of Medical Sciences, Universiti 
Sains Malaysia, Health Campus, 16150 Kota Bhnru, Kclantan 
PURPOSE: 
There is a need to know the state of serum magnesiu m in Acute Coronary Syndrome 
(ACS), which consists of STEM I, UA and NSTEMI in our population. Our aim in th is 
study is to determine the serum magnesium in ACS. Knowledge on this wi ll serve as a 
guide on fu ture in ves tigations, studies and treatment of the disease. 
METHOD: 
The serum magnesiu m level of 420 patients with chest pain was taken at the Emergency 
Department. Upon confirmation based on WHO criteria, 255 were confirmed case of 
Acute Coronary Syndrome (64 STEMI, 155 UA and 37 were confirmed as NSTEMI). 
95 healthy control samples (age range from late teen to eldetly) were taken as comprui son. 
RESULTS : 
Mean serum magnes ium in ACS group (0.88±0. 15) is sti ll with in the normal range but 
there is a significant difference as compared to the con trol group (p= 0.038). The lower 
level of serum Magnesium was mainly found in NSTEMI patients. Hypomagnesemia 
was found in 12.5% of STEMI (p=O.OO), 9.7% of UA (p=0.039), 29.7 % of 
NSTEM I(p=O.OO) and 3.2% of control patients. 9.4% of STEMI patients actually had 
hypermag nesemi a. The Odd's Rat io fo r deve loping ACS in the presence of 
hypomagnesemia in symptomatic patients is 4.559 times compared to norma l control. 
(95% Confidence In terval between 1.364 and 15.236); p=O.OO. 
CONCLUSIONS: 
Serum magnesium of ACS patients is within the normal range but tends to be at the 
lower level. Compared to the control heal t~y .populatiOn, there is a signi ficant proportion 
f I omaanesemia in ACS group and Wi thm the subgroups. NSTEMI has the hiohest o lYP o . . 4 6 f Id .· k . b proportion of hypon:agnesen~Ia Tl:ere_ IS ... o s I IS . of clevylopmg ACS in patients 
with hypoma~nescm 1 a presenting w1t h chest p,un compared to normal healthy population. 
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